ArticleFrontiers in endocrinology2021

Vildagliptin Has a Neutral Association With Dementia Risk in Type 2 Diabetes Patients.

Chin-Hsiao TsengPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.